Every 8-K that Sonnet BioTherapeutics Holdings, Inc. (SONN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SONN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SONN filings page.
Sonnet BioTherapeutics Holdings, Inc. reported that it has adjourned its special meeting of stockholders to 9:00 a.m. Eastern Time on December 2, 2025. The extra time is meant to allow more stockholders to vote on the company’s proposed business combination with Hyperliquid Strategies Inc and Rorschach I LLC, along with other proposals tied to the transaction. Stockholders of record as of October 20, 2025 remain eligible to vote and may attend the virtual meeting at the specified website. A registration statement on Form S-4 filed by HSI includes a proxy statement/prospectus, and a definitive proxy statement/prospectus was mailed on October 27, 2025, which the parties urge investors to read because it contains important information about the proposed business combination.
Sonnet BioTherapeutics Holdings, Inc. reported the results of its annual stockholder meeting held on September 26, 2025. Stockholders voted on electing five directors, approving executive compensation on an advisory basis, setting the frequency of future executive pay votes, and ratifying the independent auditor.
All five director nominees were elected, each receiving more votes "for" than "withheld." Stockholders approved the advisory vote on executive compensation with 1,209,407 votes for, 330,412 against, 5,678 abstentions and 2,152,195 broker non-votes. For the frequency of say-on-pay votes, most shares favored holding the vote every one year, with 1,394,436 votes for one year, compared with 60,801 for two years and 88,271 for three years.
Stockholders also ratified the appointment of KPMG LLP as the company’s independent registered public accounting firm for the year ending September 30, 2025, with 3,181,107 votes for, 495,000 against and 21,585 abstentions. The meeting was held based on 6,827,352 shares of common stock outstanding as of August 26, 2025, which was the record date.